Beneficios de los compuestos bioactivos del mangostán en la enfermedad de AlzheimerRevisión narrativa
- Inmaculada Navarro González
- Pedro Andreo Martínez
- Nuria García Martínez
ISSN: 2341-2526
Year of publication: 2021
Volume: 8
Issue: 1
Pages: 28-38
Type: Article
More publications in: Revista de Discapacidad, Clínica y Neurociencias: (RDCN)
Abstract
Alzheimer's disease (AD) is an irreversible neurodegenerative disease, accompanied by memory loss and progressive neurocognitive deficit. The pathophysiological changes associated with this disease are the extracellular formation of plaque deposits of the insoluble ß-amyloid peptide, the hyperphosphorylation of the tau protein forming neurofibrillary tangles, in addition to neuroinflammation, oxidative stress, alteration of energy metabolism, loss of neurons and synapses in brain. The pathogenesis of AD is not fully known because it is multifactorial. Therefore, there is no successful preventive treatment. In this sense, there is a recent interest in the bioactive compounds present in natural products and medicinal herbs for the treatment of AD due to their beneficial effects. The mangosteen, Garcinia mangostana L (Guttifereae family), is a tropical tree that produces an edible fruit with a sweet and spicy flavor; whose pericarp is a source of bioactive compounds, which have shown excellent pharmacological activity. The mangosteen pericarp has been used in traditional medicine against various diseases such as ulcers, skin infections, diarrhea or wounds. Many studies have reported that the mangosteen pericarp contains phenolic compounds, vitamins (B1, B2, C) and other bioactive substances. Xanthones and their derivatives belong to the polyphenol family, and are present in mangosteen. They have been shown to possess broad biological activity as antioxidants, anti- inflammatory, anticancer, antimicrobial, and neuroprotective activities in both in vitro and in vivo studies. Scientific evidence suggests that xanthones (obtained from mangosteen pericarp) may attenuate neurotoxicity and some of the pathophysiological changes associated with AD in both cell and animal models. In the present review, we describe the current status of the potential therapeutic effect of mangosteen extract and xanthones in cell and animal models in AD, in addition to describing the observed effects and the proposed molecular pathways.
Bibliographic References
- Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther 2013, 138 (2): 155-175. doi: https://doi.org/10.1016/j.pharmthera.2013.01.004
- Bondi MW, Edmonds EC, Salmon DP. Alzheimer's Disease: Past, Present, and Future. J Int Neuropsychol Soc 2017, 23 (9-10): 818-831. doi: https://doi.org/10.1017/s135561771700100x
- Chakravarthy M, Chen S, Dodd PR, Veedu RN. Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease. Theranostics 2017, 7 (16): 3933-3947. doi: https://doi.org/10.7150/thno.21529
- Couratier P, Lesort M, Sindou P, Esclaire F, Yardin C, Hugon J. Modifications of neuronal phosphorylated τ immunoreactivity induced by NMDA toxicity. Mol Chem Neuropathol 1996, 27 (3): 259-273. doi: https://doi.org/10.1007/BF02815108
- Do HTT, Cho J. Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer's Disease, Parkinson's Disease, and Depression with Pharmacokinetic and Safety Profiles. Int J Mol Sci 2020, 21 (17). doi: https://doi.org/10.3390/ijms21176211
- Giacobini E. Cholinergic function and Alzheimer's disease. Int J Geriatr Psychiatry 2003, 18 (Suppl 1): S1-5. doi: https://doi.org/10.1002/gps.935
- Hardy J. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem 2009, 110 (4): 1129-1134. doi: https://doi.org/10.1111/j.1471-4159.2009.06181.x
- Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256 (5054): 184-185. doi: https://doi.org/10.1126/science.1566067
- Huang H-J, Chen W-L, Hsieh R-H, Hsieh-Li HM. Multifunctional Effects of Mangosteen Pericarp on Cognition in C57BL/6J and Triple Transgenic Alzheimer’s Mice. Evid-Based Compl Alt 2014, 2014: 813672. doi: https://doi.org/10.1155/2014/813672
- Jiang T, Sun Q, Chen S. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease. Prog Neurobiol 2016, 147: 1-19. doi: https://doi.org/10.1016/j.pneurobio.2016.07.005
- Kumar K, Kumar A, Keegan RM, Deshmukh R. Recent advances in the neurobiology and neuropharmacology of Alzheimer's disease. Biomed Pharmacother 2018, 98: 297-307. doi: https://doi.org/10.1016/j.biopha.2017.12.053
- Lee Y, Kim S, Oh Y, Kim Y-M, Chin Y-W, Cho J. Inhibition of Oxidative Neurotoxicity and Scopolamine-Induced Memory Impairment by "γ"-Mangostin: "In Vitro" and "In Vivo" Evidence. Oxid Med Cell Longev 2019, 2019: 3640753. doi: https://doi.org/10.1155/2019/3640753
- Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992, 12 (2): 376-389. doi: https://doi.org/10.1523/jneurosci.12-02-00376.1992
- Menendez-Gonzalez M, Padilla-Zambrano HS, Alvarez G, Capetillo-Zarate E, Tomas-Zapico C, Costa A. Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer's Disease. Front Aging Neurosci 2018, 10: 100-100. doi: https://doi.org/10.3389/fnagi.2018.00100
- Moongkarndi P, Srisawat C, Saetun P, Jantaravinid J, Peerapittayamongkol C, Soi-ampornkul R, et al. Protective effect of mangosteen extract against beta-amyloid-induced cytotoxicity, oxidative stress and altered proteome in SK-N-SH cells. J Proteome Res 2010, 9 (5): 2076-2086. doi: https://doi.org/10.1021/pr100049v
- Nava Catorce M, Acero G, Pedraza-Chaverri J, Fragoso G, Govezensky T, Gevorkian G. Alphamangostin attenuates brain inflammation induced by peripheral lipopolysaccharide administration in C57BL/6J mice. J Neuroimmunol 2016, 297: 20-27. doi: https://doi.org/10.1016/j.jneuroim.2016.05.008
- Navarro-González I, Codina-Diaz E, Periago MJ. Propiedades beneficiosas para la salud del mangostán. Rev esp nutr comunitaria 2015, 21 (3): 29-37.
- Oh Y, Do HTT, Kim S, Kim Y-M, Chin Y-W, Cho J. Memory-Enhancing Effects of Mangosteen Pericarp Water Extract through Antioxidative Neuroprotection and Anti-Apoptotic Action. Antioxidants 2021, 10 (1): 34. doi: https://doi.org/10.3390/antiox10010034
- P A, Reddy R, Begum N, Bakshi V. Neuroprotective Effect of Garcinia Mangostana on Streptozotocin Induced Sporadic Type Alzheimer's Disease in Mice. Int J Appl Pharm Sci Res 2016, 1. doi: https://doi.org/10.21477/ijapsr.v1i1.9603
- Peng S, Li W, Lv L, Zhang Z, Zhan X. BDNF as a biomarker in diagnosis and evaluation of treatment for schizophrenia and depression. Discov Med 2018, 26 (143): 127-136.
- Phyu MP, Tangpong J. Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment. Food Chem Toxicol 2014, 70: 151-156. doi: https://doi.org/10.1016/j.fct.2014.04.035
- Pooler AM, Polydoro M, Wegmann S, Nicholls SB, Spires-Jones TL, Hyman BT. Propagation of tau pathology in Alzheimer's disease: identification of novel therapeutic targets. Alzheimer's Res Ther 2013, 5 (5): 49. doi: https://doi.org/10.1186/alzrt214
- Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F. New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. Br J Clin Pharmacol 2012, 73 (4): 504-517. doi: https://doi.org/10.1111/j.1365-2125.2011.04134.x
- Sattayasai J, Chaonapan P, Arkaravichie T, Soi-ampornkul R, Junnu S, Charoensilp P, et al. Protective Effects of Mangosteen Extract on H2O2-Induced Cytotoxicity in SK-N-SH Cells and ScopolamineInduced Memory Impairment in Mice. PLOS ONE 2013, 8 (12): e85053. doi: https://doi.org/10.1371/journal.pone.0085053
- Tanila H. The role of BDNF in Alzheimer's disease. Neurobiol Dis 2017, 97: 114-118. doi: https://doi.org/10.1016/j.nbd.2016.05.008
- Tiang N, Ahad M, Murugaiyah V, Hassan Z. Xanthone‐enriched fraction of Garcinia mangostana and α‐mangostin improve the spatial learning and memory of chronic cerebral hypoperfusion rats. J Pharm Pharmacol 2020, 72. doi: https://doi.org/10.1111/jphp.13345
- Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer's disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine 2019, 14: 5541-5554. doi: https://doi.org/10.2147/ijn.S200490
- Umeno A, Biju V, Yoshida Y. In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer's disease, Parkinson's disease, and diabetes. Free Radic Res 2017, 51 (4): 413-427. doi: https://doi.org/10.1080/10715762.2017.1315114
- Wang MH, Zhang KJ, Gu QL, Bi XL, Wang JX. Pharmacology of mangostins and their derivatives: A comprehensive review. Chin J Nat Med 2017, 15 (2): 81-93. doi: https://doi.org/10.1016/s1875- 5364(17)30024-9
- Wang SN, Li Q, Jing MH, Alba E, Yang XH, Sabaté R, et al. Natural Xanthones from Garcinia mangostana with Multifunctional Activities for the Therapy of Alzheimer's Disease. Neurochem Res 2016, 41 (7): 1806-1817. doi: https://doi.org/10.1007/s11064-016-1896-y
- Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim Biophys Acta 2014, 1842 (8): 1240-1247. doi: https://doi.org/10.1016/j.bbadis.2013.10.015
- Wang Y, Xia Z, Xu J-R, Wang Y-X, Hou L-N, Qiu Y, et al. α-Mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation. Neuropharmacology 2012, 62 (2): 871-881. doi: https://doi.org/10.1016/j.neuropharm.2011.09.016
- Weecharangsan W, Opanasopit P, Sukma M, Ngawhirunpat T, Sotanaphun U, Siripong P. Antioxidative and neuroprotective activities of extracts from the fruit hull of mangosteen (Garcinia mangostana Linn.). Med Princ Pract 2006, 15 (4): 281-287. doi: https://doi.org/10.1159/000092991
- Zhao LX, Wang Y, Liu T, Wang YX, Chen HZ, Xu JR, et al. α-Mangostin decreases β-amyloid peptides production via modulation of amyloidogenic pathway. CNS Neurosci Ther 2017, 23 (6): 526-534. doi: https://doi.org/10.1111/cns.12699